# Big Pharma: Marketing and Malpractice

> 2016 expansion pack

**Wikidata**: [Q116263517](https://www.wikidata.org/wiki/Q116263517)  
**Source**: https://4ort.xyz/entity/big-pharma-marketing-and-malpractice

## Summary
Big Pharma: Marketing and Malpractice is a 2016 expansion pack for the pharmaceutical simulation game *Big Pharma*, adding new gameplay mechanics focused on marketing strategies and malpractice challenges. Released on April 26, 2016, it is available on Microsoft Windows, macOS, and Linux, distributed digitally via platforms like Steam and GOG. The expansion enhances the base game with expanded corporate tactics and ethical dilemmas.

## Key Facts
- **Release Date**: April 26, 2016.
- **Platforms**: Microsoft Windows, macOS, Linux.
- **Game Mode**: Single-player.
- **Distribution**: Digital-only via Steam, GOG, and Humble Store.
- **Expansion Of**: The 2016 base game *Big Pharma*.
- **Supported Languages**: English (full audio and interface), French, German, Spanish, Polish, and Simplified Chinese (interface only).
- **Steam ID**: 458640.
- **Content Focus**: Introduces marketing campaigns, rival corporations, and malpractice mechanics.

## FAQs
### Q: When was Big Pharma: Marketing and Malpractice released?
A: The expansion pack was released on April 26, 2016.

### Q: What platforms is the game available on?
A: It supports Microsoft Windows, macOS, and Linux operating systems.

### Q: What new features does the expansion add to the base game?
A: It introduces marketing strategies, corporate rivalries, and malpractice challenges to deepen the simulation experience.

## Why It Matters
Big Pharma: Marketing and Malpractice enriches the original game’s pharmaceutical empire-building simulation by incorporating real-world corporate complexities. It appeals to strategy gamers by adding layers of competition and ethical decision-making, reflecting issues like aggressive marketing and regulatory scrutiny. As a digital expansion, it exemplifies the trend of post-launch content that extends a game’s lifespan and player engagement. For fans of management sims, it offers a unique blend of profit-driven mechanics and moral challenges, setting it apart from more straightforward business games.

## Notable For
- **Unique Mechanics**: First in the series to combine marketing campaigns with malpractice risks, adding strategic depth.
- **Multi-Platform Support**: Launched simultaneously on Windows, macOS, and Linux, ensuring broad accessibility.
- **Digital-Only Release**: Reflects the shift to digital distribution models in the mid-2010s gaming industry.
- **Ethical Gameplay**: Challenges players to balance profit with public health, a rare focus in business simulation games.

## Body
### Release and Platforms
Big Pharma: Marketing and Malpractice was published on **April 26, 2016**, as a digital expansion for *Big Pharma*. It launched on **Microsoft Windows**, **macOS**, and **Linux**, with system requirements tied to the base game. The expansion was distributed through major platforms, including **Steam** (App ID: 458640), **GOG**, and the **Humble Store**.

### Game Mode and Content
The expansion is designed for **single-player** mode, introducing new mechanics such as:
- **Marketing Campaigns**: Players craft advertising strategies to dominate markets.
- **Corporate Sabotage**: Rival companies engage in undercutting tactics.
- **Malpractice Scandals**: Poor decisions trigger public backlash and financial penalties.

### Distribution and Availability
- **Digital-Only**: Released exclusively via online stores, with no physical edition.
- **Storefronts**: Available on Steam, GOG (App ID: `game/big_pharma_marketing_and_malpractice`), and Humble Store (ID: `big-pharma-marketing-and-malpractice`).
- **DRM Status**: Steam version includes standard DRM; GOG release is DRM-free.

### Technical Specifications
- **Language Support**: Full English audio and interface, with partial translations for French, German, Spanish, Polish, and Simplified Chinese (interface-only).
- **Compatibility**: Requires the base game *Big Pharma* to play, with no standalone option.

### Legacy and Reception
While specific sales figures are not provided, the expansion’s presence on multiple storefronts (e.g., Steam, GOG) and its dedicated IDs (e.g., MobyGames ID: 85890) indicate sustained availability. It maintains a niche appeal among fans of pharmaceutical-themed strategy games, often bundled with the base game in later releases.

## References

1. Steam